VerityRank
By-health Co.,Ltd.
Brand & Manufacturer VerifiedChina

By-health Co.,Ltd.

By-health Co., Ltd. is China's leading dietary supplements company, publicly traded on the Shenzhen Stock Exchange and headquartered in Zhuhai, Guangdong. With five production bases in China and an annual capacity of 5 billion supplement tablets/capsules, the company achieved RMB 8.5 billion (approximately $1.2 billion) in revenue in 2024. By-health maintains its dominant market position through comprehensive product portfolios, stringent quality control, and extensive distribution networks across China.

Strengths: By-health's core strengths are its absolute leadership in China's dietary supplement market with the top brand position, comprehensive multi-channel distribution network covering pharmacies and e-commerce platforms, and stringent quality control system with pharmaceutical-grade production standards.

Weaknesses: The company faces challenges including heavy reliance on the domestic market (95% of revenue) with limited international presence, intensifying competition in China's dietary supplement sector, and vulnerability to raw material cost fluctuations.
Read More
ChinaFounded 20055K+ / 100
Listed onSZSE300146
Last updated: October 2026·By VerityRank Research Team·Methodology

Listed market data

SZ · SZSE · weeklyHistory →
Market cap
$2.4 B
Share price
≈ CNY 1.41
1Y change
-24.9%
Recent change
+1.2%

10-22 → 10-23

IPO price
+44.2%

CNY 110.00 · from 2010-12-15

· updated 2026-10-23Source ↗

Financial history

Full market history
CNY 0$0CNY 4$1.0 BCNY 8$2.0 BCNY 11$3.0 BCNY 15$4.0 B2025-112025-122026-012026-022026-032026-042026-052026-062026-072026-082026-092026-10
MonthCloseMarket capChange
  • 2026-10CNY 9.42$2.4 B-0.1%
  • 2026-09CNY 9.43$2.4 B-3.8%
  • 2026-08CNY 9.80$2.5 B-6.1%
  • 2026-07CNY 10.44$2.6 B+15.5%
  • 2026-06CNY 9.04$2.3 B-7.5%
  • 2026-05CNY 9.77$2.5 B-7.0%
  • 2026-04CNY 10.50$2.7 B-4.4%
  • 2026-03CNY 10.98$2.8 B-9.0%
  • 2026-02CNY 12.06$3.1 B-0.9%
  • 2026-01CNY 12.17$3.1 B+1.3%
  • 2025-12CNY 12.01$3 B-1.5%
  • 2025-11CNY 12.19$3.1 B—
Monthly closes · 2025-11 – 2026-10 · Full market history

In the press

All coverage →3 latest headlines
Headlines aggregated from public feeds. Sentiment tags are keyword-based, not editorial judgement.

By-Health Co., Ltd. is China's leading dietary supplement company, headquartered in Zhuhai, Guangdong Province, and listed on the Shenzhen Stock Exchange. The company operates a fully integrated business model encompassing research and development, self-production, branding, and multi-channel sales. With approximately 5,000 employees and a presence spanning 21 countries, By-Health has established itself as the dominant player in China's rapidly growing wellness and nutrition market.

Core Business

By-Health operates a comprehensive portfolio of dietary supplements and nutritional products, including vitamins, minerals, protein supplements, probiotics, meal replacements, and sports nutrition offerings. The company employs a strategic multi-brand architecture designed to capture distinct consumer segments. The flagship By-Health brand remains the cornerstone of the business, contributing approximately 70% of total revenue and maintaining its position as China's top dietary supplement brand. The Jointliff brand focuses on joint health solutions, while Life-Space has emerged as the company's fastest-growing segment, driven by surging demand for probiotic products and achieving 25.6% year-over-year growth. This diversified brand portfolio enables By-Health to serve a broad spectrum of health-conscious consumers while mitigating concentration risk.

Global Presence

While By-Health maintains its strongest market position in China, the company has expanded its footprint to 21 countries worldwide, with particular focus on Southeast Asian markets as part of its international growth strategy. Domestically, the company operates five core production bases with combined annual manufacturing capacity of 5 billion tablets and capsules, supporting its scale and supply chain resilience. The distribution network is strategically balanced across multiple channels, with pharmacy partners accounting for approximately 50% of sales, e-commerce platforms contributing 30%, and traditional retail channels representing the remaining 15%. East China and South China represent the company's most significant domestic markets, collectively accounting for approximately 55% of regional revenue.

Key Strengths

By-Health's competitive position is underpinned by substantial investment in research and development, with the company operating three dedicated R&D centers staffed by approximately 500 researchers. In 2024 alone, the company launched 120+ new products and secured 80 new patents, demonstrating a sustained commitment to innovation-driven growth. The company's robust brand equity is reflected in a brand heat score of 850 out of 1,000, indicating dominant market positioning and strong consumer loyalty. Financial performance remains solid, with 65% gross margins and consistent profitability, while the company's vertically integrated supply chain provides significant competitive advantages in quality control and cost management across its nutritional supplement portfolio.

VerityRank Score

VerityRank Score of 80/100

Quick Facts

Headquarters

Zhuhai, Guangdong, China

Founded

2005

Employees

5K+

Market cap

$2.4 B

Presence

21+ Countries

Listing

SZSE: SZ
Categories
Food & BeverageBiopharmaceuticalFoods for Special Medical Purposes (FSMP) ManufacturersFormula Food for Special Medical Purposes (FSMP) BrandsFortified Food Products IndustryFunctional Ingredients IndustryMeal Replacements IndustryNutritional Food ManufacturersProbiotics & Prebiotics IndustryProtein Powders IndustryVitamins IndustryNutritional Fortified Foods ManufacturersSpecial Dietary Food BrandsSpecial Dietary Food SuppliersTraditional Chinese Medicine & Health Products BrandsTraditional Chinese Medicine & Health Products Manufacturers & SuppliersMineral Powder Fillers & Functional Additives IndustryTrailers & Logistics Equipment Industry

18 categories · scroll for more

Related

Data Sources & Methodology

This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.

VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.

Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.

Key references: SZSE:300146